概括
瘤抑制剂p53蛋白可以通过不同的机制使细胞不朽化,其中一些突变可以防止ras瘤基因进一步转化. 这表明p53在细胞不朽化和瘤基因合作中扮演着不同的角色.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 蛋白p53在细胞对病毒,化学物质和辐射等各种转化刺激的反应中至关重要.
- p53与病毒蛋白形成复合体,包括SV40大T抗原和腺病毒E1b.
- 以前的研究将p53与细胞增殖和其表达结构与细胞永生和ras瘤基因转换敏感性联系起来.
研究的目的:
- 为了研究p53表达结构的生物特性.
- 确定p53影响细胞永生和寿命的机制.
- 探索p53的永生活动与它与ras瘤基因的合作之间的关系.
主要方法:
- 使用了一组p53互补DNA (cDNA) 表达结构.
- 检查了不同促进剂/增强剂结构对野生类型p53介导的不朽化的影响.
- 分析了产生稳定蛋白质产品的p53突变及其对细胞寿命和ras转换的影响.
主要成果:
- 发现野生型p53cDNA的细胞不朽化取决于所使用的特定促进剂/增强剂.
- p53通过编码序列重排,产生稳定的蛋白质来延长细胞寿命的独特机制.
- 细胞被某些p53突变使不朽,成为抵抗后续的ras瘤基因转化.
结论:
- 细胞不朽化和与ras瘤基因的合作是p53.3的单独功能.
- 促进者/增强者环境对p53的永生潜力产生了关键的影响.
- 突变形式的p53可以赋予抗 ras-mediated 转化,突出明显的生物活动.
相关概念视频
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...